vinflunine
CA183-001
Phase 2 small_molecule completed
Quick answer
vinflunine for Transitional Cell Carcinoma is a Phase 2 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Transitional Cell Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed